SABRIL (vigabatrin) is a prescription medicine used with various other treatments in adults and children 2 years old and older with refractory complicated partial seizures (CPS) who have not responded well enough to several other treatments and if the possible advantages surpass the threat of vision loss.
It is recommended that your doctor test your (or your child's) vision before or within 4 weeks after beginning SABRIL and a minimum of every 3 months throughout therapy up until SABRIL is quit. Inform your healthcare provider if you or your child have any side effect that troubles you or that does not vanish.
Inform your healthcare provider right away if seizures get worse. If you should take SABRIL while you are expectant, you and your health care carrier will have to decide. The most usual negative effects of SABRIL in adults consist of: obscured vision, sleepiness, dizziness, problems walking or feeling unskillful, drinking (shake), and tiredness.